281 related articles for article (PubMed ID: 18214794)
21. Genotype-phenotype correlations in Graves' disease.
Radziszewski M; Kuś A; Bednarczuk T
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101745. PubMed ID: 36828713
[TBL] [Abstract][Full Text] [Related]
22. Ocular surface and dry eye in Graves' disease.
Gürdal C; Saraç O; Genç I; Kırımlıoğlu H; Takmaz T; Can I
Curr Eye Res; 2011 Jan; 36(1):8-13. PubMed ID: 21174592
[TBL] [Abstract][Full Text] [Related]
23. The thyroid, the eyes and the gut: a possible connection.
Covelli D; Ludgate M
J Endocrinol Invest; 2017 Jun; 40(6):567-576. PubMed ID: 28063079
[TBL] [Abstract][Full Text] [Related]
24. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
25. Thyroid-related orbitopathy: concepts and management.
Della Rocca RC
Facial Plast Surg; 2007 Aug; 23(3):168-73. PubMed ID: 17691064
[TBL] [Abstract][Full Text] [Related]
26. Graves' orbitopathy.
Bhatnagar A; Tsirbas A; Douglas RS; Goldberg RA; Hoyama E
Ophthalmology; 2007 Feb; 114(2):392.e1-2. PubMed ID: 17270688
[No Abstract] [Full Text] [Related]
27. Association of Polymorphisms in MACRO Domain Containing 2 With Thyroid-Associated Orbitopathy.
Khong JJ; Burdon KP; Lu Y; Leonardos L; Laurie KJ; Walsh JP; Gajdatsy AD; Ebeling PR; McNab AA; Hardy TG; Stawell RJ; Davis GJ; Selva D; Tsirbas A; Montgomery GW; Macgregor S; Craig JE
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3129-37. PubMed ID: 27304844
[TBL] [Abstract][Full Text] [Related]
28. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
29. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
Wiersinga WM
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
[TBL] [Abstract][Full Text] [Related]
30. [The manifestations of 496 cases with thyroid-related immune orbitopathy and normal thyroid function].
Sun F; Song G; Tian W; Zhao H; Pan Y
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):283-6. PubMed ID: 11877209
[TBL] [Abstract][Full Text] [Related]
31. Perspectives in pharmacological management of Graves' hyperthyroidism and orbitopathy.
Bartalena L; Lai A; Tanda ML
Expert Rev Clin Immunol; 2008 May; 4(3):321-9. PubMed ID: 20476922
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
33. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
[TBL] [Abstract][Full Text] [Related]
34. Lysosome-related genes are regulated in the orbital fat of patients with graves' ophthalmopathy.
Chen MH; Liao SL; Chen MH; Tsou PL; Shih MJ; Chang TC; Chuang LM
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4760-4. PubMed ID: 18552385
[TBL] [Abstract][Full Text] [Related]
35. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Genere N; Stan MN
Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the management of thyroid associated orbitopathy: A promising roadmap.
Kurian DE; Kalra S; Kapoor N
J Pak Med Assoc; 2022 Mar; 72(3):567-571. PubMed ID: 35320248
[TBL] [Abstract][Full Text] [Related]
38. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
39. Graves' disease and Graves' orbitopathy following COVID-19.
Lanzolla G; Marcocci C; Marinò M
J Endocrinol Invest; 2021 Sep; 44(9):2011-2012. PubMed ID: 33964007
[No Abstract] [Full Text] [Related]
40. Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma.
Nutting CM; Shah-Desai S; Rose GE; Norton AP; Plowman PN
Eye (Lond); 2006 Jun; 20(6):645-8. PubMed ID: 16123786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
